Torrent Pharmaceuticals reported Q4 FY26 total revenue of ₹4,197 crore, a 42% year-on-year increase.
India market was the largest contributor with ₹2,215 crore revenue, growing 43% compared to Q4 FY25.
Other international markets showed strong growth with a 68% increase, while US, Germany, and Brazil also posted double-digit growth.